SIRT1 and in situ carcinoma: These findings demonstrate that NMN protects against CIS-AKI by activating the NAD<sup>+</sup>-SIRT1 pathway, thereby reducing oxidative stress and inflammation, and suggest its potential as a therapeutic strategy for CIS-AKI.